Join
Live feed
·
INSIDERFilingvia Quantisnow
AcelRx Pharmaceuticals Inc. logo

SEC Form 4: Palmer Pamela P was granted 122,500 shares and covered exercise/tax liability with 7,927 shares, increasing direct ownership by 17% to 777,184 units to satisfy tax liability

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACRX (AcelRx Pharmaceuticals Inc.) and more on Quantisnow.

SEC Form 4: Palmer Pamela P was granted 122,500 shares and covered exercise/tax liability with 7,927 shares, increasing direct ownership by 17% to 777,184 units to satisfy tax liability | Quantisnow